BNTC Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 17:52):

Stats
Dagens volum	6 758.00
Gjennomsnittsvolum	82 838.00
Markedsverdi	18.98M
EPS	$0 ( 2024-02-12 )
Neste inntjeningsdato	( $-0.780 ) 2024-05-13
Last Dividend	$0.0450 ( 2018-06-01 )
Next Dividend	$0 ( N/A )
P/E	-0.0300
ATR14	$0.0460 (0.63%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-06	Banks Jerel A.	Buy	466 554	Options (right to buy)
2024-03-06	Boston Megan	Buy	200 004	Options (right to buy)
2023-12-06	Smith Edward F	Buy	35 000	Options (right to buy)
2023-12-06	Francis Peter	Buy	35 000	Options (right to buy)
2023-12-06	Buchi J Kevin	Buy	35 000	Options (right to buy)

INSIDER POWER
100.00
Last 38 transactions
Buy: 2 361 696 \| Sell: 57 465

Volum Korrelasjon

Lang: -0.19 (neutral)

Kort: 0.31 (neutral)

Signal:(75.766) Neutral

Benitec Biopharma Inc Korrelasjon

10 Mest positive korrelasjoner
RNLX	0.862
TTSH	0.842
BAFN	0.831
OVLY	0.829
VIOT	0.826
GGAL	0.826
ASLE	0.824
CASH	0.823
BOOM	0.82
TELA	0.818

10 Mest negative korrelasjoner
MBCN	-0.811

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Benitec Biopharma Inc Korrelasjon - Valuta/Råvare

0.76
( moderate )

0.70
( moderate )

0.00
( neutral )

0.78
( moderate )

-0.50
( neutral )

-0.56
( weak negative )

Benitec Biopharma Inc Økonomi

Annual	2023
Omsetning:	$75 000.00
Bruttogevinst:	$-306 000 (-408.00 %)
EPS:	$-14.12

FY	2023
Omsetning:	$75 000.00
Bruttogevinst:	$-306 000 (-408.00 %)
EPS:	$-14.12

FY	2022
Omsetning:	$73 000.00
Bruttogevinst:	$64 000.00 (87.67 %)
EPS:	$-38.62

FY	2021
Omsetning:	$59 000.00
Bruttogevinst:	$-64 000.00 (-108.47 %)
EPS:	$-3.23

Financial Reports:

No articles found.

Benitec Biopharma Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Benitec Biopharma Inc Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$0.0450	2018-06-01
Last Dividend	$0.0450	2018-06-01
Next Dividend	$0	N/A
Payout Date	2018-06-08
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$0.0450	--
Avg. Dividend % Per Year	0.00%	--
Score	0.01	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-04-29)

$0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

0.01

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2018	$0.0450	0.01%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-358.57	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-1.024	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-2.05	1.500	-10.00	-10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	3.62	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	3.55	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	3.55	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.0198	-1.500	9.67	-10.00	[0 - 0.6]
interestCoverageTTM	-1 446.13	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	-7.01	2.00	-2.34	-4.67	[0 - 30]
freeCashFlowPerShareTTM	-7.01	2.00	-3.51	-7.01	[0 - 20]
debtEquityRatioTTM	0.0273	-1.500	9.89	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.820	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	-355.61	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-42.71	1.000	-10.00	-10.00	[0.2 - 2]
assetTurnoverTTM	0.00286	0.800	-3.31	-2.65	[0.5 - 2]
Total Score				-1.934

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-0.813	1.000	-0.183	0	[1 - 100]
returnOnEquityTTM	-2.05	2.50	-10.00	-10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-7.01	2.00	-2.34	-7.01	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-7.01	2.00	-2.34	-4.67	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.00690	1.500	-3.29	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-296.16	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-3.45

Benitec Biopharma Inc

Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.